Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Andrew Hastie"'
Autor:
Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThe objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV). This was a phase 3, randomize
Externí odkaz:
https://doaj.org/article/12bc65c505f04005a7c324c7c830dbbb
Autor:
Joon Hyung Kim, John Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang, Eun Ju Choo, Maribel Co, Andrew Hastie, David Shu Cheong Hui, Junya Irimajiri, Jacob Lee, Edward Man-Fuk Leung, Haiwen Tang, Tomomi Tsuru, Philip Watson, Zhenhua Wu, Chong-Jen Yu, Yanfei Yuan, Toufik Zahaf, Anthony L. Cunningham, Anne Schuind
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 2050-2057 (2021)
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy (VE) against herpes zoster (HZ) in adults ≥50 years of age (YOA). This post-hoc an
Externí odkaz:
https://doaj.org/article/3f26a5280f08465fa9cb53f30f8d89cb
Autor:
Ning Jiang, Joon Hyung Kim, Haiwen Tang, Andrew Hastie, Tomomi Tsuru, Junya Irimajiri, Edward M. F. Leung, Chong-Jen Yu, David S.C. Hui, Shinn-Jang Hwang, Anthony L. Cunningham, Eun Ju Choo, Anne Schuind, Maribel Co, John Diaz-Decaro, Toufik Zahaf, Zhenhua Wu, Philip Watson, Yanfei Yuan, Jacob Lee
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy (VE) against herpes zoster (HZ) in adults ≥50 years of age (YOA). This post-hoc an
Autor:
Paola Pirrotta, Juan Carlos Tinoco, Isabelle Schenkenberger, Tino F. Schwarz, Huey-Shinn Cheng, Céline Boutry, Meral Esen, Charles P. Andrews, Beate Moeckesch, Andrew Hastie, Pavel Kosina, Chong-Jen Yu, Thiago Junqueira Avelino-Silva, Javier Díez-Domingo, Lars Rombo, Shinn-Jang Hwang, Johan Berglund, Dan Curiac, Jean Beytout, Anne Schuind, Bruno Salaun, Tamara Eckermann, Karlis Pauksens, Dae Won Park, Marc Dionne, Toufik Zahaf, Carol Pretswell, Jukka Markkula, Cláudia Murta de Oliveira, Georg Plassmann, Meng Shi, Benita Ukkonen, Emmanuel Di Paolo, Hee Jin Cheong, Murdo Ferguson, Chiu-Shong Liu, Covadonga Caso, Anthony L. Cunningham, Eun Ju Choo, Wayne Ghesquiere, Cristiano Zerbini
Publikováno v:
CLINICAL INFECTIOUS DISEASES
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background This ongoing follow-up study evaluated the persistence of efficacy and immune responses for 6 additional years in adults vaccinated with the glycoprotein E (gE)-based adjuvanted recombinant zoster vaccine (RZV) at age ≥50 years in 2 pivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95436cf2c10fe3340b7037fb23513abc
https://trepo.tuni.fi/handle/10024/141029
https://trepo.tuni.fi/handle/10024/141029
Publikováno v:
Revista Internacional de Ciencias del Deporte, Vol 9, Iss 31, Pp 48-59 (2013)
AbstractThe study examined the effects of different methods of practice three track and field skills (hurdles, high jump and shot put) on students performance, from both qualitative (systematic observation), and quantitative (time, height, and distan
Externí odkaz:
https://doaj.org/article/6b2ec49c54f44896a4a0428a6b93dd7b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Adriana Bastidas, Lars Rombo, Bruno Salaun, Andrew Hastie, Karlis Pauksens, Adaora Enemuo, Jan Smetana, Tomas Mrkvan, Caroline Hervé, Anne Schuind, Grégory Catteau, Stephanie Volpe, Tino F. Schwarz
Publikováno v:
The Journal of Infectious Diseases
Background The adjuvanted recombinant zoster vaccine (RZV) is highly immunogenic and efficacious in adults ≥50 years of age. We evaluated (1) long-term immunogenicity of an initial 2-dose RZV schedule, by following up adults vaccinated at ≥60 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e595647a35a971af6f1c641cc0573415
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-427103
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-427103
Publikováno v:
Revista Portuguesa de Ciências do Desporto. 13:23-37
Autor:
Andrea Zivi, Andrew Hastie, Peter Lawrence, Christine Stephens, Paul Elvin, Malcolm R Ranson, Ruud van der Noll, Jan H.M. Schellens, Sy Amy Cheung, Taito Esaki, Kenji Tamura, Marcelo Marotti, Michelle D. Garrett, Paul K. Stockman, Udai Banerji, Barry R. Davies, Emma Dean
Publikováno v:
Cancer Research. 73:LB-66
Background: AZD5363 is an oral, potent, and selective inhibitor of AKT1, 2 and 3, with activity in a wide range of tumor cell lines and xenografts dependent upon PI3K/AKT signaling. Methods: Two phase I studies (NCT01226316 [West], NCT01353781 [Japan
Publikováno v:
RICYDE. Revista Internacional de Ciencias del Deporte; ene2013, Vol. 9 Issue 31, p48-59, 12p, 5 Charts